What is the most recent earnings date for MXCT stock?
MAXCYTE INC (MXCT) last reported earnings on 3/24/2026.
NASDAQ:MXCT • US57777K1060
Past quarterly earnings results for MAXCYTE INC (MXCT), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -0.06 | -0.08 | 26.47% | 40.00% | 7.3M | 9.594M | -23.91% | -16.02% |
| Q3 2025 | -0.09 | -0.11 | 19.79% | 18.18% | 6.829M | 8.537M | -20.01% | -16.35% |
| Q2 2025 | -0.12 | -0.11 | -13.86% | -33.33% | 8.507M | 9.719M | -12.47% | -18.43% |
| Q1 2025 | -0.10 | -0.11 | 6.63% | -11.11% | 10.39M | 9.869M | 5.28% | -8.39% |
| Q4 2024 | -0.10 | -0.12 | 19.64% | -100.00% | 8.693M | 8.086M | 7.51% | -44.51% |
| Q3 2024 | -0.11 | -0.13 | 12.56% | - | 8.164M | 7.522M | 8.53% | 1.99% |
| Q2 2024 | -0.09 | -0.13 | 30.34% | 10.00% | 10.429M | 8.079M | 29.09% | 15.33% |
| Q1 2024 | -0.09 | -0.13 | 32.13% | 18.18% | 11.342M | 7.611M | 49.02% | 32.25% |
| Q4 2023 | -0.05 | -0.07 | 31.92% | - | 15.666M | 13.356M | 17.30% | 26.14% |
| Q3 2023 | -0.11 | -0.10 | -5.73% | -83.33% | 8.005M | 9.247M | -13.44% | -24.77% |
| Q2 2023 | -0.10 | -0.10 | -2.12% | -25.00% | 9.043M | 11.003M | -17.82% | -5.90% |
| Q1 2023 | -0.11 | -0.11 | 3.71% | -175.00% | 8.576M | 8.495M | 0.96% | -26.00% |
| Q4 2022 | -0.05 | -0.07 | 29.97% | - | 12.42M | 13.154M | -5.58% | 22.36% |
| Q3 2022 | -0.06 | -0.08 | 28.26% | -100.00% | 10.64M | 10.639M | 0.01% | 4.93% |
| Q2 2022 | -0.08 | -0.08 | 1.96% | -60.00% | 9.61M | 9.407M | 2.16% | 35.16% |
| Q1 2022 | -0.04 | -0.07 | 45.53% | - | 11.59M | 8.629M | 34.31% | - |
| Q4 2021 | -0.05 | -0.06 | 9.22% | 28.57% | 10.15M | 9.645M | 5.24% | -33.56% |
| Q3 2021 | -0.03 | -0.05 | 38.73% | - | 10.14M | 7.521M | 34.82% | - |
| Q2 2021 | -0.05 | -0.07 | 24.59% | - | 7.11M | 5.847M | 21.60% | -34.73% |
| Q4 2020 | -0.07 | -0.10 | 30.69% | - | 15.277M | - | - | |
| Q2 2020 | - | - | 10.892M | - | - |
Notes
MAXCYTE INC (MXCT) last reported earnings on 3/24/2026.
MAXCYTE INC (MXCT) beat EPS estimates and missed revenue estimates in the most recent quarter.
In the last 4 quarters, MAXCYTE INC (MXCT) has beaten EPS estimates in 3 out of 4 releases.